In the fourth seminar of the Repurposing TIN series, partner organisations will describe how they have successfully furthered their mission to translating discoveries from the laboratory to marketplace for the benefit of patients. We will discuss new (and non-traditional) collaboration, business and funding models arising to bridge stakeholders, and also how these partnerships have helped change prescribing policies and build a more supportive overall pathway.
To keep updated with activities and opportunities from the Repurposing TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
232
11/22/2021
This video highlights the work of 2020 Regenerative Medicine TIN PDS awardee Dr Hassan Rashidi, with a project titled “Dissecting the cross-talk between parenchymal and non-parenchymal derivatives within human pluripotent stem cell-derived 3D hepatospheres (3D Heps) using spatial transcriptomics”.
Hassan comments on the importance of basic science in the translational pathway.
The next Pilot Data Scheme funding opportunity for the Repurposing TIN is now open for applications until 24th October 2021. Learn more and apply: https://www.ucl.ac.uk/therapeutic-innovation-networks/funding-opportunities
191
10/22/2021
This video highlights the work of 2020 Repurposing TIN PDS awardee Dr Pilar Acedo, with a project titled “Repurposing p53 reactivators for the treatment of pancreatic cancer”.
Pilar highlights the value of working in a hospital at UCL to incorporate patient into her translational project.
The next Pilot Data Scheme funding opportunity for the Repurposing TIN is now open for applications until 24th October 2021. Learn more and apply: https://www.ucl.ac.uk/therapeutic-innovation-networks/funding-opportunities
210
10/15/2021
In this video, Helen Cooksley from the TRO highlights the motivation behind launching the TINs Pilot Data Scheme (funded by the Wellcome Trust) to support Early Career Researchers in translation.
It also features 2020 awardees, Dr Nikolas Pontikos, Dr Pilar Acedo and Dr Hassan Rashidi, who highlight how the scheme enabled them to learn crucial skills, generate data & lead to follow-on funding.
1008
10/8/2021
In the third seminar of the Repurposing TIN series our speakers, from industry, biotech, charities and non-profit organisations, will explore how new collaborative models with multi-stakeholder partnerships are being employed to maximise synergy among different sectors and the impact that such models have had in certain fields of medicine (e.g. rare and paediatric disorders and oncology) where drug repurposing plays a prominent role. We will also discuss what major opportunities and pitfalls to look out for in drug repurposing partnering.
To keep updated with activities and opportunities from the Repurposing TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
124
10/7/2021
During this webinar Healx, an AI-powered and patient-inspired technology company, and Cures Within Reach, a philanthropic leader in drug, device and nutraceutical repurposing research, will discuss the regulatory and commercial challenges associated with the redevelopment of existing drugs and some potential strategies to navigate these hurdles, opportunities in this research space, funding approaches and their impact. Success stories and case studies will also be presented.
To keep updated with activities and opportunities from the Repurposing TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
135
9/30/2021
Speakers:
Prof Dan Bracewell - "Manufacturing of Exosomes"
Prof Ahad Rahim - "Lentiviral Vector Packaging"
To keep updated with activities and opportunities from the Biologics TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
78
7/20/2021
The first seminar of the series will focus on technological challenges and will showcase the innovative solutions developed by industry-leaders in the Drug Repurposing field. The Medicines Discovery Catapult will guide us through various approaches to identify drug candidates and guide development of treatments for unmet medical needs with specific case studies. Additionally, speakers will explore the world of machine learning and artificial intelligence and will introduce the audience to topics like classification and predictive models, image-to-drug translation, and 3D CNNs for enhanced activity models. Presentations from Healx and Biovista, will explore the powerful impact of artificial intelligence on drug repurposing efforts to find new therapeutic opportunities.
To keep updated with activities and opportunities from the Repurposing TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
149
7/20/2021